Overview Investor FAQs Executive Management Independent Directors Page
·What is Pheton’s business?
 Pheton Holdings Ltd is a healthcare solution provider dedicated to the development and commercialization of treatment software used for brachytherapy. We develop the treatment software to promote the efficiency, accuracy, and safety of brachytherapy, which enables high-precision delivery of radiation to treat cancer effectively. Our lead product, Beijing Feitian’s Treatment Planning System (FTTPS), is a key component of radiation therapy used in treating cancer patients, placing radioactive sources inside the patient that kill cancer cells and shrink tumors. We are committed to leveraging our products and services to establish a potential new standard of care across multiple malignant tumor applications.

·Where is Pheton’s corporate headquarters?
 Room 306, NET Building, Hong Jun Ying South Road, Chaoyang District, Beijing, China

·When was the Company founded?
 The company was established in 1998.

·On which exchange is Pheton’s stock traded and what is the ticker symbol?
 Pheton trades on the NASDAQ exchange under the ticker PTHL.

·When does Pheton’s fiscal year end?
 The fiscal year ends on December 31

·Who is Pheton’s independent auditor?
 Marcum Asia CPAs LLP serves as the Company’s auditor.

·Who is Pheton’s US legal counsel?
 Pheton’s US legal counsel is Hunter Taubman Fischer & Li LLC.

·Who is Pheton’s transfer agent and share registrar?
 Pheton’s transfer agent and share registrar is VStock Transfer, LLC.

·Where can I find all the SEC filings for Pheton?
 Information on all SEC filings may be found on the tab "Financials" on this site or by using the SEC’s EDGAR database found at the SEC’s website,https://www.sec.gov/edgar/.

·Whom should I contact regarding investor inquiries?
 Pheton Holdings Ltd.
 Email: ir@ftzy.com.cn

 Lambert by LLYC
 Jackson Lin
 E-mail: jlin@lambert.com
Copyright © 2012-2024 Beijing Feitian Zhaoye Technology Co., Limited(北京飞天兆业科技有限责任公司) 京ICP备13049465号-1 ,All rights reserved
未经许可 严禁复制 建议使用1024X768分辨率浏览本站